# A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

> **NCT00183807** · PHASE2 · TERMINATED · sponsor: **University of Southern California** · enrollment: 6 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** irinotecan, cisplatin, celecoxib

## Key facts

- **NCT ID:** NCT00183807
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** 2006-02
- **Final completion:** 2008-03
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Insufficient Accrual
- **Last updated:** 2014-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00183807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00183807, "A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00183807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*